fulvestrant has been researched along with dactinomycin in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.55) | 18.2507 |
| 2000's | 14 (63.64) | 29.6817 |
| 2010's | 7 (31.82) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chen, Z; German, Z; Kirsch, EA; Shaul, PW; Sherman, TS; Yuhanna, IS | 1 |
| Leung, SW; Man, RY; Quan, A; Teoh, H | 1 |
| Gorodeski, GI; Pal, D | 1 |
| Chikuma, M; Kobayashi, T; Masuda, S; Nagao, M; Sasaki, R | 1 |
| Garcia, E; Giudicelli, Y; Lacasa, D | 1 |
| Dong, HY; Hashimoto, S; Inadera, H; Matsushima, K; Nagai, S; Suzuki, T; Toyoda, N; Yamashita, T | 1 |
| Dutertre, M; Mancini, MA; Mancini, MG; O'Malley, BW; Patel, K; Smith, CL; Stenoien, DL | 1 |
| Sampath, D; Winneker, RC; Zhang, Z | 1 |
| Hayashi, T; Iguchi, A; Jayachandran, M; Sumi, D | 1 |
| Asagiri, K; Habara, T; Konishi, H; Kudo, T; Nakatsuka, M; Noguchi, S; Takata, M | 1 |
| Adachi, T; Aoki, N; Mori, C; Tsuda, K; Tsujimoto, G; Yasuda, K; Yoshinaga, M | 1 |
| Navarrete, E; Perusquía, M | 1 |
| Hyttinen, JM; Kaarniranta, K; Kyrylenko, S; Ojala, J; Salminen, A; Suuronen, T; Thornell, A | 1 |
| Chang, HH; Chien, YS; Ding, WH; Kao, YH; Ku, HC; Lee, MJ; Liao, WJ; Lin, H; Liu, CW; Wu, MH | 1 |
| Dougherty, SM; Klinge, CM; Li, Y; Manavalan, TT; Riggs, KA; Wickramasinghe, NS | 1 |
| El Gebeily, G; Fiset, C | 1 |
| Alber, S; Chen, G; Salama, G; Shusterman, V; Yang, X | 1 |
| Arias, A; Banchio, C; Catania, VA; Mottino, AD; Rigalli, JP; Ruiz, ML; Villanueva, S; Vore, M | 1 |
| Buyukafsar, K; Kurt, AH; Tiftik, RN; Ulker, S; Un, I | 1 |
| Cardenas, H; Díaz, P; Lopez, J; Orihuela, PA; Oróstica, ML; Parada-Bustamante, A; Reuquén, P; Rocco, J; Rojas, I | 1 |
| Dündar, Y; Erol, K; Kaygısız, B; Önkol, T; Şahin, MF; Yasemin Özatik, F | 1 |
1 review(s) available for fulvestrant and dactinomycin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
21 other study(ies) available for fulvestrant and dactinomycin
| Article | Year |
|---|---|
Estrogen acutely stimulates endothelial nitric oxide synthase in H441 human airway epithelial cells.
Topics: Animals; Arginine; Bronchi; Calcimycin; Cell Line; Dactinomycin; Enzyme Activation; Epithelial Cells; Estradiol; Estrogen Receptor alpha; Female; Fulvestrant; Humans; Kinetics; Menstruation; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction; Sheep; Uterus | 1999 |
Differential effects of 17beta-estradiol and testosterone on the contractile responses of porcine coronary arteries.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Androgen Antagonists; Androgen Receptor Antagonists; Animals; Coronary Vessels; Cycloheximide; Cyproterone; Dactinomycin; Dose-Response Relationship, Drug; Endothelin-1; Estradiol; Estrogen Antagonists; Female; Flutamide; Fulvestrant; In Vitro Techniques; Isotonic Solutions; Male; Potassium Chloride; Receptors, Estrogen; Serotonin; Swine; Tamoxifen; Testosterone; Vasoconstriction | 2000 |
Involvement of estrogen receptors alpha and beta in the regulation of cervical permeability.
Topics: Adult; Binding Sites; Cells, Cultured; Cervix Uteri; Dactinomycin; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Fulvestrant; Humans; Nucleic Acid Synthesis Inhibitors; Permeability; Receptors, Estrogen; RNA, Messenger | 2000 |
The oviduct produces erythropoietin in an estrogen- and oxygen-dependent manner.
Topics: Animals; Cycloheximide; Dactinomycin; Erythropoietin; Estradiol; Estrogen Antagonists; Fallopian Tubes; Female; Fulvestrant; Gene Expression; Hypoxia; Mice; Mice, Inbred ICR; Organ Culture Techniques; Ovary; Oxygen; Protein Synthesis Inhibitors; RNA, Messenger | 2000 |
Estradiol stimulation of c-fos and c-jun expressions and activator protein-1 deoxyribonucleic acid binding activity in rat white adipocyte.
Topics: Adipocytes; Animals; Cycloheximide; Dactinomycin; DNA; Estradiol; Female; Fulvestrant; Gene Expression; Genes, fos; Genes, jun; Male; Nucleic Acid Synthesis Inhibitors; Ovariectomy; Progesterone; Protein Synthesis Inhibitors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transcription Factor AP-1 | 2000 |
WISP-2 as a novel estrogen-responsive gene in human breast cancer cells.
Topics: Air Pollutants, Occupational; Benzhydryl Compounds; Breast Neoplasms; CCN Intercellular Signaling Proteins; Cycloheximide; Dactinomycin; Dose-Response Relationship, Drug; Estradiol; Estrogen Receptor Modulators; Female; Fulvestrant; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Intercellular Signaling Peptides and Proteins; Keratins; Neoplasm Proteins; Phenols; Repressor Proteins; RNA, Messenger; Time Factors; Transcription Factors; Tumor Cells, Cultured | 2000 |
FRAP reveals that mobility of oestrogen receptor-alpha is ligand- and proteasome-dependent.
Topics: Bacterial Proteins; Biological Transport; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Dactinomycin; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Fulvestrant; HeLa Cells; Histone Acetyltransferases; Humans; Leupeptins; Ligands; Luminescent Proteins; Microscopy, Fluorescence; Multienzyme Complexes; Nuclear Matrix; Nuclear Receptor Coactivator 1; Proteasome Endopeptidase Complex; Protein Structure, Tertiary; Receptors, Estrogen; Tamoxifen; Transcription Factors; Transcription, Genetic | 2001 |
Cyr61, a member of the CCN family, is required for MCF-7 cell proliferation: regulation by 17beta-estradiol and overexpression in human breast cancer.
Topics: Adenocarcinoma; Antibodies; Breast Neoplasms; Cell Division; Cysteine-Rich Protein 61; Dactinomycin; DNA, Neoplasm; Epidermal Growth Factor; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Fulvestrant; Gene Expression Regulation, Neoplastic; Growth Substances; Humans; Immediate-Early Proteins; In Situ Hybridization; Intercellular Signaling Peptides and Proteins; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcriptional Activation; Tumor Cells, Cultured | 2001 |
Estrogen prevents destabilization of endothelial nitric oxide synthase mRNA induced by tumor necrosis factor alpha through estrogen receptor mediated system.
Topics: Animals; Aorta; Cattle; Dactinomycin; Endothelium, Vascular; Enzyme Activation; Estradiol; Estrogen Antagonists; Estrogens; Fulvestrant; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Necrosis Factor-alpha | 2001 |
Bisphenol A stimulates NO synthesis through a non-genomic estrogen receptor-mediated mechanism in mouse endothelial cells.
Topics: Animals; Benzhydryl Compounds; Blotting, Western; Cells, Cultured; Cycloheximide; Dactinomycin; Endothelium; Environmental Exposure; Estradiol; Estrogen Antagonists; Estrogens, Non-Steroidal; Fulvestrant; Mice; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Phenols; Protein Synthesis Inhibitors; Receptors, Estrogen | 2002 |
Promoting insulin secretion in pancreatic islets by means of bisphenol A and nonylphenol via intracellular estrogen receptors.
Topics: Animals; Benzhydryl Compounds; Dactinomycin; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrogens, Non-Steroidal; Fulvestrant; Glucose; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Male; Phenols; Rats; Rats, Wistar; Receptors, Estrogen; RNA, Messenger; Time Factors | 2005 |
Evidence that 17alpha-estradiol is biologically active in the uterine tissue: antiuterotonic and antiuterotrophic action.
Topics: Animals; Calcium Chloride; Cycloheximide; Dactinomycin; Estradiol; Estrogens; Female; Fulvestrant; In Vitro Techniques; Muscle Relaxation; Norepinephrine; Potassium Chloride; Propranolol; Rats; Rats, Wistar; Stereoisomerism; Tamoxifen; Uterine Contraction; Uterus | 2005 |
Regulation of ER alpha signaling pathway in neuronal HN10 cells: role of protein acetylation and Hsp90.
Topics: Acetylation; Animals; Benzoquinones; Cell Line; Dactinomycin; Dehydroepiandrosterone; Diethylstilbestrol; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogens; Estrogens, Non-Steroidal; Fulvestrant; Genes, Reporter; Histone Deacetylase Inhibitors; Histone Deacetylases; HSP90 Heat-Shock Proteins; Humans; Hydroxamic Acids; Lactams, Macrocyclic; Neurons; Protein Synthesis Inhibitors; Selective Estrogen Receptor Modulators; Signal Transduction; Sirtuin 2; Sirtuins; Transcriptional Activation; Valproic Acid | 2008 |
Octylphenol stimulates resistin gene expression in 3T3-L1 adipocytes via the estrogen receptor and extracellular signal-regulated kinase pathways.
Topics: 3T3-L1 Cells; Adipocytes; Adiponectin; Animals; Benzhydryl Compounds; Blood Glucose; Butadienes; Cycloheximide; Dactinomycin; Dose-Response Relationship, Drug; Endocrine Disruptors; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Extracellular Signal-Regulated MAP Kinases; Fulvestrant; Half-Life; Leptin; MAP Kinase Kinase 1; Mice; Nitriles; Nucleic Acid Synthesis Inhibitors; Phenols; Phosphorylation; Protein Kinase Inhibitors; Protein Synthesis Inhibitors; Resistin; RNA Stability; RNA, Messenger; Signal Transduction; Time Factors; Up-Regulation | 2008 |
Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells.
Topics: 3' Untranslated Regions; Apoptosis Regulatory Proteins; Breast Neoplasms; Cell Line, Tumor; Cycloheximide; Dactinomycin; Down-Regulation; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; MicroRNAs; Nucleic Acid Synthesis Inhibitors; Promoter Regions, Genetic; Protein Synthesis Inhibitors; ras GTPase-Activating Proteins; RNA-Binding Proteins; RNA, Antisense; Tamoxifen | 2009 |
4-Hydroxytamoxifen inhibits K(+) currents in mouse ventricular myocytes.
Topics: Animals; Dactinomycin; Electric Conductivity; Estradiol; Female; Fulvestrant; Heart Ventricles; Kinetics; Mice; Muscle Cells; Patch-Clamp Techniques; Potassium; Receptors, Estrogen; Tamoxifen; Transcription, Genetic | 2010 |
Regional genomic regulation of cardiac sodium-calcium exchanger by oestrogen.
Topics: Animals; Blotting, Western; Cycloheximide; Dactinomycin; Electrophysiology; Estradiol; Estrogen Antagonists; Estrogens; Female; Fulvestrant; Heart; Immunohistochemistry; Male; Myocardium; Myocytes, Cardiac; Phenethylamines; Protein Synthesis Inhibitors; Rabbits; Sodium-Calcium Exchanger; Sulfonamides | 2011 |
Induction of hepatic multidrug resistance-associated protein 3 by ethynylestradiol is independent of cholestasis and mediated by estrogen receptor.
Topics: Animals; Bile; Bile Acids and Salts; Cells, Cultured; Cholestasis; Dactinomycin; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogens; Ethinyl Estradiol; Fulvestrant; Glutathione; Liver; Male; Multidrug Resistance-Associated Proteins; Nucleic Acid Synthesis Inhibitors; Phosphorylation; Primary Cell Culture; Proto-Oncogene Proteins c-jun; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; RNA, Messenger; Time Factors; Up-Regulation | 2013 |
G protein-coupled estrogen receptor1 (GPER1) may mediate Rho-kinase (ROCK-2) up-regulation in coronary endothelial cells.
Topics: Animals; Benzodioxoles; Cell Movement; Cells, Cultured; Coronary Circulation; Dactinomycin; Endothelial Cells; Enzyme Inhibitors; ErbB Receptors; Estradiol; Estrogen Antagonists; Fulvestrant; Male; Nitric Oxide; Nitriles; Phenols; Progesterone; Protein Synthesis Inhibitors; Pyrazoles; Quinazolines; Quinolines; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; rho-Associated Kinases; Testosterone; Tyrphostins; Up-Regulation | 2013 |
Estradiol increases cAMP in the oviductal secretory cells through a nongenomic mechanism.
Topics: Animals; Catechol O-Methyltransferase; Cyclic AMP; Dactinomycin; Estradiol; Estrogen Receptor Antagonists; Female; Fulvestrant; Myocytes, Smooth Muscle; Oviducts; Rats; Receptors, Estrogen; Signal Transduction | 2014 |
The Effects of p-nonylphenol on the Myometrial Contractile Activity.
Topics: Animals; Benzamides; Cycloheximide; Dactinomycin; Dose-Response Relationship, Drug; Estradiol; Female; Fulvestrant; Norepinephrine; Phenols; Potassium Chloride; Propranolol; Rats; Tocolytic Agents; Uterine Contraction | 2015 |